Kevin Sayer

Chairman, President & CEO
DexCom, Inc.

Kevin Sayer joined Dexcom as president and chief operating officer in 2011. In this executive role, Sayer is responsible for research and development, manufacturing, clinical, regulatory, finance, sales and marketing functions. During his tenure with Dexcom, he has been instrumental in leading the development of new technology, including the Dexcom G5 Mobile CGM System, the Dexcom G4 PLATINUM System with Share and several other product launches in the United States and Europe.

Prior to joining Dexcom, Sayer served as chief financial officer of Biosensors International, a medical technology company focused on the development, manufacturing and commercialization of medical devices used in interventional cardiology and critical care procedures. He also served as CFO of MiniMed, Inc. from 1994 until its acquisition by Medtronic, Inc. in 2001.

Sayer earned his master's and bachelor’s degrees in accounting and information systems from Brigham Young University.